Skip to search formSkip to main contentSkip to account menu

Nonachlazine

Known as: Nonachlazin, 10H-Phenothiazine, 2-chloro-10-(3-(hexahydropyrrolo(1,2-a)pyrazin-2(1H)-yl)-1-oxopropyl)-, dihydrochloride, AZACLORZINE 
Coronary vasodilator with a novel mechanism of action; proposed as antianginal agent.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Neurotropic drugs belonging to various groups (fluphenazine, nonachlazine, trifluperidol fluacizine, imipramine, diazepam… 
1985
1985
It has been shown in vitro that nonachlazine stabilizes rat myocardial lysosomal membranes and activates total acid phosphatase… 
1984
1984
The preparation nonachlazine, which is the dihydrochloride of 10-[~-N-(l,4-diazabicyclo [4.3.0]nonanyl)propionyl]-2… 
1983
1983
The activity of a new antianginal drug, nonachlazine, synthetized in the Institute of Pharmacology, Academy of Medical Sciences… 
1980
1980
: It has been shown that nonachlazin in a dose of 6 mg/kg injected intravenously to cats 15 minutes after occlusion of the left… 
1980
1980
Nonachlazin binds in vitro heparin in blood plasma and aqueous medium. This interaction complies with logarithmic dependence… 
1978
1978
Instravenous infusion of ildamen (0.8-1 mg/kg) into anesthesized cats caused an increase in coronary blood flow and oxygen… 
1976
1976
: Nonachlazine (2 micrometer) blocked significantly the uptake 1 of endogenic noradrenaline in the myocardial tissues and in… 
1976
1976
The binding of nonachlazine (NON), imipramine (IMI), and noradrenalin (NA) with model phospholipid membrane vesicles (liposomes…